351 related articles for article (PubMed ID: 37048117)
1. Cellular Distribution of Secreted Phospholipase A2 in Lungs of IPF Patients and Its Inhibition in Bleomycin-Induced Pulmonary Fibrosis in Mice.
Jaiswal A; Rehman R; Dutta J; Singh S; Ray A; Shridhar M; Jaisankar J; Bhatt M; Khandelwal D; Sahoo B; Ram A; Mabalirajan U
Cells; 2023 Mar; 12(7):. PubMed ID: 37048117
[TBL] [Abstract][Full Text] [Related]
2. Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis.
Barnes JW; Duncan D; Helton S; Hutcheson S; Kurundkar D; Logsdon NJ; Locy M; Garth J; Denson R; Farver C; Vo HT; King G; Kentrup D; Faul C; Kulkarni T; De Andrade JA; Yu Z; Matalon S; Thannickal VJ; Krick S
Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L141-L154. PubMed ID: 31042083
[TBL] [Abstract][Full Text] [Related]
3. Identification and immunological characterization of PLA2G2A and cell death-associated molecular clusters in idiopathic pulmonary fibrosis.
Lv W; Mao H; Ruan Y; Li S; Shimizu K; Zhang L; Zhang C
Life Sci; 2023 Oct; 331():122071. PubMed ID: 37673297
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin F(2alpha) receptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-beta.
Oga T; Matsuoka T; Yao C; Nonomura K; Kitaoka S; Sakata D; Kita Y; Tanizawa K; Taguchi Y; Chin K; Mishima M; Shimizu T; Narumiya S
Nat Med; 2009 Dec; 15(12):1426-30. PubMed ID: 19966781
[TBL] [Abstract][Full Text] [Related]
5. MAP3K19 Is a Novel Regulator of TGF-β Signaling That Impacts Bleomycin-Induced Lung Injury and Pulmonary Fibrosis.
Boehme SA; Franz-Bacon K; DiTirro DN; Ly TW; Bacon KB
PLoS One; 2016; 11(5):e0154874. PubMed ID: 27144281
[TBL] [Abstract][Full Text] [Related]
6. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
[TBL] [Abstract][Full Text] [Related]
7. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
[TBL] [Abstract][Full Text] [Related]
8. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
9. SEMA3B inhibits TGFβ-induced extracellular matrix protein production and its reduced levels are associated with a decline in lung function in IPF.
Yombo DJK; Ghandikota S; Vemulapalli CP; Singh P; Jegga AG; Hardie WD; Madala SK
Am J Physiol Cell Physiol; 2024 Jun; 326(6):C1659-C1668. PubMed ID: 38646784
[TBL] [Abstract][Full Text] [Related]
10. Saracatinib, a Selective Src Kinase Inhibitor, Blocks Fibrotic Responses in Preclinical Models of Pulmonary Fibrosis.
Ahangari F; Becker C; Foster DG; Chioccioli M; Nelson M; Beke K; Wang X; Justet A; Adams T; Readhead B; Meador C; Correll K; Lili LN; Roybal HM; Rose KA; Ding S; Barnthaler T; Briones N; DeIuliis G; Schupp JC; Li Q; Omote N; Aschner Y; Sharma L; Kopf KW; Magnusson B; Hicks R; Backmark A; Dela Cruz CS; Rosas I; Cousens LP; Dudley JT; Kaminski N; Downey GP
Am J Respir Crit Care Med; 2022 Dec; 206(12):1463-1479. PubMed ID: 35998281
[No Abstract] [Full Text] [Related]
11. The Anti-fibrotic and Anti-inflammatory Potential of Bone Marrow-Derived Mesenchymal Stem Cells and Nintedanib in Bleomycin-Induced Lung Fibrosis in Rats.
Gad ES; Salama AAA; El-Shafie MF; Arafa HMM; Abdelsalam RM; Khattab M
Inflammation; 2020 Feb; 43(1):123-134. PubMed ID: 31646446
[TBL] [Abstract][Full Text] [Related]
12. A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis.
Bauer Y; Tedrow J; de Bernard S; Birker-Robaczewska M; Gibson KF; Guardela BJ; Hess P; Klenk A; Lindell KO; Poirey S; Renault B; Rey M; Weber E; Nayler O; Kaminski N
Am J Respir Cell Mol Biol; 2015 Feb; 52(2):217-31. PubMed ID: 25029475
[TBL] [Abstract][Full Text] [Related]
13. Thromboxane-Prostanoid Receptor Signaling Drives Persistent Fibroblast Activation in Pulmonary Fibrosis.
Suzuki T; Kropski JA; Chen J; Carrier EJ; Chen X; Sherrill TP; Winters NI; Camarata JE; Polosukhin VV; Han W; Rathinasabapathy A; Gutor S; Gulleman P; Sabusap C; Banovich NE; Tanjore H; Freeman ML; Tada Y; Young LR; Gokey JJ; Blackwell TS; West JD
Am J Respir Crit Care Med; 2022 Sep; 206(5):596-607. PubMed ID: 35728047
[No Abstract] [Full Text] [Related]
14. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO
Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491
[No Abstract] [Full Text] [Related]
15. Role of lung ornithine aminotransferase in idiopathic pulmonary fibrosis: regulation of mitochondrial ROS generation and TGF-β1 activity.
Lee JU; Song KS; Hong J; Shin H; Park E; Baek J; Park S; Baek AR; Lee J; Jang AS; Kim DJ; Chin SS; Kim UJ; Jeong SH; Park SW
Exp Mol Med; 2024 Feb; 56(2):478-490. PubMed ID: 38413821
[TBL] [Abstract][Full Text] [Related]
16. Isoforms of secretory group two phospholipase A (sPLA2) in mouse ocular surface epithelia and lacrimal glands.
Wei Y; Pinhas A; Liu Y; Epstein S; Wang J; Asbell P
Invest Ophthalmol Vis Sci; 2012 May; 53(6):2845-55. PubMed ID: 22467583
[TBL] [Abstract][Full Text] [Related]
17. Fibulin-1c regulates transforming growth factor-β activation in pulmonary tissue fibrosis.
Liu G; Cooley MA; Jarnicki AG; Borghuis T; Nair PM; Tjin G; Hsu AC; Haw TJ; Fricker M; Harrison CL; Jones B; Hansbro NG; Wark PA; Horvat JC; Argraves WS; Oliver BG; Knight DA; Burgess JK; Hansbro PM
JCI Insight; 2019 Jul; 5(16):. PubMed ID: 31343988
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effects.
Overed-Sayer C; Miranda E; Dunmore R; Liarte Marin E; Beloki L; Rassl D; Parfrey H; Carruthers A; Chahboub A; Koch S; Güler-Gane G; Kuziora M; Lewis A; Murray L; May R; Clarke D
Thorax; 2020 Sep; 75(9):754-763. PubMed ID: 32709610
[TBL] [Abstract][Full Text] [Related]
19. Caffeic acid ethanolamide induces antifibrosis, anti-inflammatory, and antioxidant effects protects against bleomycin-induced pulmonary fibrosis.
Huang CW; Lee SY; Du CX; Wu ST; Kuo YH; Ku HC
Biomed Pharmacother; 2024 Apr; 173():116298. PubMed ID: 38394850
[TBL] [Abstract][Full Text] [Related]
20. Investigating the role of platelets and platelet-derived transforming growth factor-β in idiopathic pulmonary fibrosis.
Chong DLW; Mikolasch TA; Sahota J; Rebeyrol C; Garthwaite HS; Booth HL; Heightman M; Denneny EK; José RJ; Khawaja AA; Duckworth A; Labelle M; Scotton CJ; Porter JC
Am J Physiol Lung Cell Mol Physiol; 2023 Oct; 325(4):L487-L499. PubMed ID: 37643008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
